Yubo International Biotech Limited (YBGJ)
Yubo International Biotech Limited, through its subsidiaries, focuses on the research, development, and application of endometrial stem cells. The company offer...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 0.0119
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- 0.0449
- Volume Ratio
- 0.00
- Turnover Ratio
- --
News
- HK Stock Alerts · 5 hours ago
Hong Kong stock movement: China National Pharmaceutical Group rises 18.89%: Half-year net profit doubles, renamed SBP Group
- Price Alert · Aug 16 at 08:46 PM
U.S. stock night market volatility: FDA restarts review + rating upgrade, Capricor surges 58%
- TradingView · Aug 14 at 05:41 AM
Yubo International Biotech Ltd 2Q 2026: Revenue $165.49K, Net income ($268.72K), EPS $0— 10-Q Summary
- PUBT · Aug 14 at 05:38 AM
Yubo International Biotech Q2 FY26 net loss widens 7.6% to $268,721; revenue holds at no revenue
- Earnings Watch · Mar 31 at 03:14 PM
Yubo International Biotech Limited | 10-K: FY2025 Revenue: USD 12.35 K
- Wallstreetcn · Mar 26 at 11:19 AM
Yubico's stock price drop widened to 30%
